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ABSTRACT 
 
Formalinized aqua based liver organ vaccines for Angara disease (AD)/hydropericardium-hepatitis 
syndrome (HHS) are effective for the control of the disease. The experimental formalinized 10, 7.5 and 5% 
liver organ vaccines showed significant differences in efficacy from 2.5 and 1% liver organ vaccines. 
However, 10, 7.5 and 5% liver organ vaccines differed non significantly from one another. The vaccines of 
10 and 7.5% liver organ concentrations showed the best results in terms of reducing mortality among the 
given groups, while 5% liver organ vaccine proved the best in both efficacy and economy. The vaccination 
of AD showed positive effect on the immune response of the chicks against Newcastle disease virus. 
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INTRODUCTION 
 
Angara disease (AD)/hydropericardium-hepatitis 
syndrome (HHS) was first recognized in broiler flocks 
in Angara Goth near Karachi, Pakistan, during late 
1987 (Jaffery, 1988). Because the disease emerged in 
that specific geographic area, HHS was locally referred 
to as "Angara disease". Since its first outbreak, AD 
widely prevails in the country. The outbreaks of the 
disease were also recorded in Mexico in 1989 in the 
highly dense poultry producing states. 
The preliminary work on the aetiology and 
pathogenicity of the causative agent and controlling the 
problem was described by Ahmad et al. (1989), Anjum 
et al. (1989) and Cheema et al. (1989). The vaccines, 
including formalinized aqua based liver tissue vaccines 
and oil based tissue culture vaccines, were developed 
for the control of the syndrome (Chishti et al., 1989; 
Afzal and Ahmad, 1990; Ahmad et al., 1990; 1991). 
Both types of vaccines on challange were reported to 
show 100% protection in vaccinated  flocks  (Ahmad    
et al., 1990; Ahmad, 1999). Since sporadic outbreaks 
despite AD vaccination are reported in the field, the 
present study was undertaken to re-evaluate the 
efficacy of Angara disease vaccine produced at Poultry 
Research Institute, Rawalpindi and to improve its 
formulation for efficacy and economy.  
 
MATERIALS AND METHODS 
 
Experimental chicks 
For the present study, day-old chicks were 
procured from a local hatchery and reared at Poultry 
Research Institute, Rawalpindi till the age of 45 days. 
The chicks were given feed and water ad libitum. 
Afterwards the chicks were randomly divided and 
separated. 
 
i) Experimental chicks for biological titre (LD50) of   
   AD  virus 
For this purpose, a total of 50 chicks were included 
in the trial. The chicks were divided into five groups 
named I, II, III, IV and V, with 10 chicks in each 
group. 
 
ii) Experimental chicks for vaccination 
In this trial a total of 180 chicks were included. 
The chicks were divided into six groups named 1, 2, 3, 
4, 5 and 6, with 30 chicks in each group. 
 
Infectious liver organ filtrate as virus source 
The liver organ showing gross lesions including 
inflammation, typical discolouration and necrosis were 
collected from the freshly dead broiler chickens 
exhibiting typical symptoms of AD. A 20% suspension 
of liver tissue was prepared in phosphate buffer saline. 
The suspension was sonicated at 40 MHz for 3 minutes 
and centrifuged at 3000 rpm for 15 minutes. The 
supernatant was used as virus source in the study. 
 
Biological titre (LD50) of AD virus filtrate 
The biological titre i.e. lethal dose for 50% (LD50) 
of the virus suspension per 1 ml was determined in 25 
days old broiler chickens of groups I, II, III, IV and V 
by inoculating subcutaneously, undiluted 20% filtrate 
and its dilutions of 10
-1 ,10
-2 ,10
-3 and 10
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LD50 was calculated by the method described by 
Ahmad (1999). 
AD vaccines 
Five different concentrations of AD vaccine as 1.0, 
2.5, 5.0, 7.5 and 10.0% aqua based infectious liver 
organ tissue filtrate, inactivated with 0.1% formalin, 
were prepared and named as vaccines I, II, III, IV and 
V, respectively, for further reference in the study.  
 
Comparative efficacy of vaccines 
The chicks of groups 1, 2, 3, 4 and 5 were 
vaccinated with vaccines I, II, III, IV and V 
respectively, at the recommended dose of 0.30 ml per 
chick, at the age of 18 days. The chicks of group 6 were 
kept without vaccination and were used as negative 
control. At the age of 25 days, the chicks of each group 
were further sub-grouped into three groups named 1a, 
1b, 1c, 2a, 2b, 2c, 3a, 3b, 3c, 4a, 4b, 4c, 5a, 5b, 5c, 6a, 
6b and 6c, having 10 chicks each. 
 
Challenge protection 
The chicks in all subgroups were subjected to 
challenge protection with the 20% viral suspension at 
the rate of 1 ml subcutaneously per chick 7 days post 
vaccination at the age of 25 days. 
 
Newcastle disease  vaccination and serology 
All the experimental chicks were vaccinated twice 
with Newcastle disease (ND) at the age of 7 and 21 
days at the recommended dose rate and route of 
vaccination to evaluate the immune response of the AD 
affected birds. Blood samples were collected from the 
chicks of groups 5 and 6, 20 days after second ND 
vaccination, sera were separated and antibodies titres 
against ND virus were determined by the 
haemagglutination inhibition test. Geometric mean 
titres (GMT) were calculated by the method described 
by Burgh (1977). 
 
Statistical analysis 
The data on the challenge protection test were 
subjected to the statistical analysis for the interpretation 
of results by using one way analysis of variance (Steel 
and Torrie, 1984). 
RESULTS AND DISCUSSION 
 
Biological titre (LD50) 
The biological titre (LD50) of the 20% viral filtrate 
was determined as 10
1.1 per ml inoculated subcuta- 
neously in 25 days old broiler chicks (Table 1). This 
finding is different from the previously reported viral 
titres of 10
4 to 10
5 per ml of 20% liver filtrate studied at 
the inception of the disease problem (Anonymous, 
1989). The reduced number of outbreaks of the disease 
due to intensive and widely adopted vaccination might 
have reduced the pathogenicity of the causative agent 
(Ahmad, 1999). 
 
Efficacy of vaccines 
Formalinized aqua based infected liver organ 
filtrate vaccines for Angara Disease (AD) were 
effective for the control of the disease. Statistical 
analysis of the data showed that the 10, 7.5 and 5% 
infected liver organ vaccines had significantly better 
efficacy than 2.5 and 1% infected liver organ vaccines. 
Their results were, however, non significantly different 
from one another. Vaccine I (10%) and Vaccine II 
(7.5%) showed the best results in terms of protection 
among the given groups (Table 2). However, in the 
light of the present study and keeping in view the cost 
element in the production of infectious liver, vaccine III 
(5%) can be recommended as the best in efficacy and 
economy.  Moreover, vaccination against AD had a 
good effect on the development of the serum antibodies 
titres against NDV (Table 3). The low antibodies titres 
against NDV in the group 6 chicks is supportive of the 
finding of Naeem et al. (1995) that infection of AD is 
immunosuppressive. The vaccination against AD gives 
protection against the subclinical infection also. Good 
performance of the inactivated AD vaccines without 
priming with live vaccine is also suggestive of the 
exposure of the chicks to AD virus at early days of their 
age. 
Table 1: Determination of biological titre LD50 
 
Group  Dilution  No. of chicks 
inoculated 
No. of chicks 
died 
No. of chicks 
survived 
Proportion 
death ratio 
% age 
1  undiluted      10      5     5  17/22  77.3 
2 10
-1      10      4     6  12/23  52.2 
3 10
-2      10      3     7  8/26  30.8 
4 10
-3      10      3     7  5/30  16.7 
5 10
-4      10      2     8  2/34   5.9 
 Proportionate distance (PD) = 52.2 - 50.0 / 52.2 - 30.8 = 0.1   so, LD50 = 10
1.1 
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Based on the findings of the present study it can be 
concluded that the chicks should be vaccinated against 
AD even in the absence of wide spread clinical 
prevelance of the disease to control the subclinical AD 
virus infection and the related complications. 
Furthermore, since different standard vaccines are in 
use in the field, the efficacy of the vaccine should be 
evaluated from time to time. 
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Table 2: Comparative   efficacy  of  AD vaccines  of  different  concentrations  in  challange    
                    protection test 
 
Subgroup
*       Mortality in AD vaccine treatment groups 
 VAC-I  VAC-II  VAC-III VAC-IV  VAC-V  NC 
A 1  2 0  0  0 4 
B 1  1 0  0  0 5 
C 2  2 1  0  0 5 
Total 4  5  1
** 0
** 0
** 14 
AD = Angara disease. VAC = Vaccine. NC = Negative control. 
  * 10 birds in each sub group. 
** 
Statistically significant from VAC I & II (P< 0.05). 
Table 3: Immune   response   against   
     Newcastle disease  vaccines 
 
Group Vaccinated 
against 
GMT of antibodies 
against ND virus* 
5  AD + NDV  11 
6 NDV  8 
* = 10 HA units used in HI test.   
AD = Angara diseases.  NDV = Newcastle 
disease virus. GMT = Geometric mean titre. 
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